BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Merck Invests Over €300 Million in New Daejeon Bioprocessing Center, Elevating Asia-Pacific's Biologics Sector and Generating 300 Jobs

Site to supply products to customers for development and production of biologics New Bioprocessing Production Center in Daejeon strengthens footprint of...

March 20, 2024 | News

South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection

Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...

March 19, 2024 | News

Lunit's Bid to Acquire Volpara Gains Momentum with New Zealand High Court's Initial Nod

Volpara Health Technologies (Volpara; ASX:VHT), renowned for its AI-driven solutions in cancer diagnostics, is on the brink of a transformative merger with...

March 14, 2024 | News

TiumBio Advances TU2218 in Phase 2a Trial with Pembrolizumab for Three Cancer Types

TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab TU2218 demonstrated a favorable safety and a synerget...

March 12, 2024 | News

ImmunAbs Announces Triumph in Phase 1 Clinical Trial of Novel Autoimmune Disease Therapy, IM-101

ImmunAbs, a leading clinical-stage biotechnology company focused on developing novel antibody therapeutics, today announced the successful completion of th...

March 12, 2024 | News

SK bioscience and Sanofi to Boost Global Vaccine Supply with Major Expansion of L HOUSE Manufacturing Plant

The company will expand its manufacturing plant, L HOUSE, with additional cGMP-level facility. The new space will serve as a production base for the pne...

March 08, 2024 | News

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj

Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use in South Korea as an adjuvant cell th...

February 27, 2024 | News

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

February 26, 2024 | News

Oscotec/ ADEL Launch First Human Trial for Novel Alzheimer's Treatment ADEL-Y01

In a significant stride towards Alzheimer's disease (AD) treatment, Oscotec Inc. in collaboration with ADEL Inc., has announced the initiation of f...

February 26, 2024 | News

STARmed Expedites Global Rollout of EUSRA and ELRA Products in Collaboration with Olympus

Previously distributed by Taewoong Medical Co., Ltd., a Korean gastrointestinal medical device manufacturer, EUSRA and ELRA products will n...

February 16, 2024 | News

Samsung Biologics and LegoChem Biosciences Forge Strategic Partnership for ADC Development and Manufacturing

The collaboration marks a pivotal milestone as Samsung Biologics commits to providing cutting-edge antibody development and drug substance manufact...

February 12, 2024 | News

Zymedi initiates first human dosing of ZMA001 in a clinical trial for Pulmonary Arterial Hypertension in South Korea

In collaboration with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), Zymedi is conducting this t...

February 09, 2024 | News

Cathay Biotech and 3P.COM Forge Groundbreaking Joint Venture to Propel Sustainable Composite Innovations

In a strategic move towards sustainable innovation, Cathay Biotech Inc. of China and 3P.COM Co. Limited of South Korea have signed a landmark joint venture...

February 09, 2024 | News

Luye Pharma Licenses Rivastigmine Patch to Myung In Pharm for South Korea Commercialization

The agreement for the collaboration was signed at a ceremony attended by executives from both sides. Dianbo Liu, Chairman of the Board of Directors of Luye...

February 06, 2024 | News

Stay Connected